SCHEMBL3402237

SCHEMBL3402237

COC(=O)c1sc(Cl)nc1-c1cccc(OC)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
CNR1 P21554 1/20 0.43
POLB P06746 1/20 0.42
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 3/20 0.39
BTK Q06187 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HTT P42858 2/20 0.38
GAA P10253 1/20 0.38
KDM4E B2RXH2 2/20 0.37
HPGD P15428 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
GFER P55789 1/20 0.37
ESR2 Q92731 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405784 0.84 ALDH1A1 (0.45) CNR1POLBKMT2AMEN1ALDH1A1
SCHEMBL3405221 0.79 LMNA (0.41) LMNAPOLBKMT2AMEN1ALDH1A1
SCHEMBL11278098 0.76 LMNA (0.64) LMNAKMT2AMEN1ALDH1A1NPSR1
SCHEMBL9750566 0.74 CDC7 (0.51) LMNAKMT2AMEN1ALDH1A1HTT
SCHEMBL11289442 0.73 MAPT (0.52) LMNAKMT2AALDH1A1NPSR1HTT
SCHEMBL3406917 0.73 ALDH1A1 (0.46) LMNAPOLBKMT2AMEN1ALDH1A1
SCHEMBL28140144 0.73 GAA (0.50) LMNAPOLBKMT2AMEN1ALDH1A1
SCHEMBL13993307 0.72 ALDH1A1 (0.37) LMNAPOLBKMT2AMEN1ALDH1A1
SCHEMBL3406390 0.71 LMNA (0.41) LMNAPOLBKMT2AMEN1ALDH1A1
SCHEMBL18377766 0.71 BTK (0.49) CNR1ALDH1A1BTKGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2158199-B1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2010-11-17 EP disclosed
WO-2008152418-A1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2008-12-18 WO disclosed
US-20080312255-A1 PIPERDINE COMPOUNDS AND USES THEREOF-911 ASTRAZENECA AB (SE) 2008-12-18 US disclosed
US-20080312255-A1 PIPERDINE COMPOUNDS AND USES THEREOF-911 ASTRAZENECA AB (SE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312255-A1 PIPERDINE COMPOUNDS AND USES THEREOF-911 NISCH, PIR, QDPR LMNA 2265/4885CNR1 575/4885POLB 1019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.